Provided by Tiger Trade Technology Pte. Ltd.

Attovia Therapeutics

21.40
+0.70003.38%
Post-market: 21.480.0817+0.38%18:34 EDT
Volume:180.37K
Turnover:3.74M
Market Cap:920.82M
PE:-14.36
High:21.81
Open:20.74
Low:19.87
Close:20.70
52wk High:24.32
52wk Low:16.15
Shares:43.03M
Float Shares:17.33M
Volume Ratio:1.33
T/O Rate:1.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4900
EPS(LYR):-15.3508
ROE:--
ROA:--
PB:-7.34
PE(LYR):-1.39

Loading ...

Attovia Therapeutics Could Serve as Key Player in Immunology, Inflammation, RBC Says

MT Newswires Live
·
Yesterday

Attovia Therapeutics Initiated at Buy by Citigroup

Dow Jones
·
Yesterday

Morgan Stanley Initiates Coverage on Attovia Therapeutics With Overweight Rating

MT Newswires Live
·
Yesterday

Attovia Therapeutics Inc : Leerink Partners Initiates Coverage with Outperform Rating; Target Price $52

THOMSON REUTERS
·
Yesterday

RBC Initiates Attovia Therapeutics at Outperform, Speculative Risk With $45 Price Target

MT Newswires Live
·
Yesterday

Citigroup Initiates Attovia Therapeutics at Buy With $30 Price Target

MT Newswires Live
·
Yesterday

Attovia initiated with a Buy at Citi

TIPRANKS
·
Yesterday

Attovia initiated with an Overweight at Morgan Stanley

TIPRANKS
·
Yesterday

U.S. Research Roundup-Adobe, Braveheart Bio, CACI International

Reuters
·
Yesterday

Attovia Therapeutics, Inc. (ATTO) Initiated with a Buy at RBC Capital

TIPRANKS
·
Yesterday

Goldman Sachs Reports Sale of 105,807 Attovia Therapeutics Shares Worth $2.22 Million

Reuters
·
Aug 14

Major Investor Makes Bold Move Into Attovia Therapeutics

TIPRANKS
·
Aug 11

venBio Global Strategic Fund IV Reports Attovia Therapeutics Common Share Acquisition Valued at $6.5 Million

Reuters
·
Aug 11

Major Investor Doubles Down on Attovia Therapeutics in Bold New Move

TIPRANKS
·
Aug 07

Attovia Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

GlobeNewswire
·
Aug 07

Biotech Firm Attovia Therapeutics Surges Nearly 29% in Nasdaq Debut

Stock News
·
Aug 06

Stock Track | Attovia Therapeutics Soars 23.53% in Nasdaq Debut After Upsized $289 Million IPO

Stock Track
·
Aug 06

Attovia indicated to open at $20, IPO priced at $17

TIPRANKS
·
Aug 05

Attovia indicated to open at $24, IPO priced at $17

TIPRANKS
·
Aug 05

Attovia Therapeutics Poised to Surge in NASDAQ Debut After Upsized $289 Million IPO

Reuters
·
Aug 05